查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1929560

透析试剂盒市场：依材料、透析方法、定价模式、最终用户和销售管道，全球预测，2026-2032年

Dialysis Kits Market by Material, Modality, Pricing Model, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年透析试剂盒市值为 3.3321 亿美元，预计到 2026 年将成长至 3.5923 亿美元，预计到 2032 年将达到 5.2584 亿美元，复合年增长率为 6.73%。

关键市场统计数据
基准年 2025 3.3321亿美元
预计年份：2026年 3.5923亿美元
预测年份 2032 5.2584亿美元
复合年增长率 (%) 6.73%

在复杂的医疗环境中，透析试剂盒市场应兼顾临床绩效、筹资策略、法规遵循和营运弹性。

随着人口结构变化、慢性病流行以及医疗服务模式创新等因素共同重塑临床需求和采购重点，透析试剂盒市场环境正面临日益严峻的策略挑战。临床医生和供应链管理人员越来越关注如何在不同医疗环境中平衡成本压力和营运实际情况，同时确保产品品质稳定、符合监管要求并确保患者安全。因此，相关人员正在寻求能够将临床绩效指标与筹资策略和营运可行性连结起来的分析。

产品设计创新、分散式医疗服务模式以及日益严格的监管正在重新定义供应商选择和筹资策略

在技​​术进步、医疗模式变革和相关人员期望不断变化的影响下，医疗产业正经历着一场变革性的转变。试剂盒设计和材料的创新提高了易用性和感染控制水平，使得更多操作能够在门诊和家庭环境中安全地进行。同时，医疗服务模式正变得更加分散化，更加重视门诊中心和居家医疗，这就要求试剂盒必须高度便携、易于使用，并相容于远距临床监测。

评估 2025 年美国关税如何影响透析试剂盒供应链的供应风险放大、采购调整和策略采购决策。

由于美国将于2025年实施一系列关税，透析试剂盒相关人员面临供应链复杂性和成本的累积挑战。关税带来的成本压力正在影响上游原料分销和零件进口，迫使采购团队重新评估筹资策略和库存管理政策。因此，各组织正在权衡短期成本增加与采购多元化、近岸外包和加强供应商合作等策略优势。

详细的細項分析重点在于治疗方式、终端使用者环境、材料、分销管道和定价策略对采购和临床整合的影响。

关键的細項分析表明，治疗方法、最终用户、材料组合、销售管道和定价模式均对采购决策和临床工作流程产生不同的影响。在基于治疗方法的分类中，血液透析试剂盒、血液净化试剂盒和腹膜透析试剂盒之间的差异不仅决定了其与治疗通讯协定的临床相容性，还决定了组件组装的复杂性和灭菌要求。因此，临床团队在考虑不同治疗方式的表现特征以及物流要求的同时，也需要考虑这些因素，以确保其能无缝地融入治疗流程。

区域观点：美洲、欧洲、中东和非洲以及亚太地区趋势对透析试剂盒监管、采购和应用的影响

区域趋势对透析试剂盒产业的法规结构、供应链结构和临床应用模式有显着影响。在美洲，采购和临床路径反映了医疗支付模式的多样性以及对扩大门诊和居家照护的日益重视，从而推动了对便捷性、安全性和远端监测功能更优的试剂盒的需求。该地区的相关人员往往优先考虑供应商的可靠性和合约履约保证，以确保患者照护的连续性。

产业竞争洞察：产品差异化、垂直整合、服务生态系统与供应链策略如何重塑公司定位

製造商和供应商之间的竞争正围绕着四大策略支柱：透过临床性能实现产品差异化、组件采购的垂直整合、服务和支援生态系统以及供应链韧性。主要企业正投资于提升安全性、易用性和设备相容性的设计特性，同时也在完善品管体系，以加快监管核准并保持产品在不同地区的一致性。这种对差异化的关注正推动企业与医疗机构建立合作关係，以检验产品在实际应用中的表现，并加速临床医生对产品的接受度。

加强透析试剂盒采购韧性、临床协作、设计创新和服务主导差异化的实用建议

为了获得策略优势，产业领导者应采取一系列合作措施，将临床价值与商业性韧性结合。首先，应优先考虑关键零件的供应商多元化和双重采购策略，以减轻关税和地缘政治动盪的影响。透过在合约条款中加入价格调整条款、库存保留协议以及针对替代供应商的快速资格认证流程，来强化合约。其次，应使采购规范与临床团队保持一致，确保产品选择既能满足病患安全需求，又能兼顾营运限制。这将减少实施过程中的摩擦，并避免因不相容造成的废弃物。

解释如何运用混合调查方法（结合专家访谈、监管分析和供应链情境检验）得出可操作的产业结论

本分析的研究结合了定性专家直接对话和定量营运及监管数据整合，以确保获得可靠且可操作的见解。关键资料来源包括对医院采购主管、各科室临床医生、供应链经理和高级产品开发主管的结构化访谈，以收集有关绩效重点、采购限制和实施障碍的第一手资讯。这些第一手资讯与监管指南、材料安全标准和行业最佳实践等第二手资料进行三角验证，从而更好地理解营运影响。

最终的综合分析将临床、采购和供应链的优先事项提炼为可操作的策略重点领域，以稳定透析供应并改善患者照护。

总之，透析试剂盒市场格局是由临床需求、筹资策略和供应链实际情况的交互作用所决定。决策者必须仔细考虑不同透析方式的具体要求、终端用户的差异、材料的权衡取舍、分销管道和定价模式，才能提供安全高效的透析服务。关税趋势和区域差异进一步增加了采购决策的复杂性，但同时也为透过灵活的采购策略、设计创新和服务型交付实现策略差异化创造了机会。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依材料分類的透析试剂盒市场

  • 聚乙烯
  • PVC

9. 依透析方式分類的透析试剂盒市场

  • 血液透析套装
  • 血液灌流套件
  • 腹膜透析套装

第十章 透析试剂盒市场定价模式

  • 免洗工具包
  • 可重复使用套装

第十一章 以最终用户分類的透析设备市场

  • 门诊手术中心
  • 透析中心
  • 居家医疗
  • 医院

第十二章 透析试剂盒市场销售管道

  • 直销
  • 经销合作伙伴
  • 在线的

第十三章 各地区透析设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 透析设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国透析设备市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国透析设备市场

第十七章 中国透析设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Allmed Medical GmbH
  • AngioDynamics, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Atlantic Biomedical Pvt. Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bellco Srl
  • Dialife SA
  • Farmasol
  • Fresenius Medical Care AG & Co. KGaA
  • Guangdong Kanghua Healthcare Co., Ltd.
  • JMS Co., Ltd.
  • Kawasumi Laboratories, Inc.
  • Mar Cor Purification, Inc.
  • Medline Industries, Inc.
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • NxStage Medical, Inc.
  • Outset Medical, Inc.
  • Pall Corporation
  • Poly Medicure Limited
  • Rockwell Medical, Inc.
  • Teleflex Incorporated
  • Thermo Fisher Scientific Inc.
  • Toray Medical Co., Ltd.
  • Zhejiang Asia-Pacific Pharmaceutical Co., Ltd.
Product Code: MRR-0A380695181B

The Dialysis Kits Market was valued at USD 333.21 million in 2025 and is projected to grow to USD 359.23 million in 2026, with a CAGR of 6.73%, reaching USD 525.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 333.21 million
Estimated Year [2026] USD 359.23 million
Forecast Year [2032] USD 525.84 million
CAGR (%) 6.73%

Framing the dialysis kits landscape to align clinical performance, procurement strategy, regulatory compliance, and operational resilience in complex care environments

The dialysis kits landscape is undergoing a period of heightened strategic importance as demographic trends, chronic disease prevalence, and care-delivery innovations converge to reshape clinical demand and procurement priorities. Clinicians and supply chain managers are increasingly focused on ensuring consistent product quality, regulatory compliance, and patient safety while balancing cost pressures and the operational realities of diverse care settings. As a result, stakeholders require analyses that bridge clinical performance characteristics with sourcing strategies and operational feasibility.

This introduction establishes the foundational context needed to navigate that complexity. It synthesizes how modality choices interact with end-user requirements and how materials and sales approaches influence both cost structures and logistical footprints. Furthermore, it highlights the imperative to align clinical protocols with supplier selection and inventory management so that care continuity and patient outcomes remain paramount. By framing the discussion around these interdependent factors, this section prepares decision-makers to weigh trade-offs, prioritize investments, and identify the levers that will most effectively drive quality, resilience, and efficiency across dialysis kit programs.

How innovations in product design, decentralization of care delivery, and heightened regulatory focus are redefining supplier selection and procurement strategies

The industry is experiencing transformative shifts driven by technological advances, changing care models, and evolving stakeholder expectations. Innovations in kit design and materials have improved usability and infection control, enabling more procedures to be safely performed in outpatient and home-based settings. Simultaneously, care delivery is decentralizing, with greater emphasis on ambulatory centers and home healthcare, which requires kits that are portable, simple to use, and compatible with remote clinical oversight.

In parallel, procurement strategies are moving beyond short-term cost metrics toward total-cost-of-care thinking, where lifecycle considerations, sterilization protocols, and compatibility with existing equipment shape supplier relationships. Regulatory scrutiny is intensifying around device traceability and biocompatibility, prompting manufacturers to invest in compliance infrastructure and quality systems. Together, these forces are accelerating product differentiation and encouraging collaboration between clinical, commercial, and supply chain teams to co-develop solutions that meet evolving clinical pathways and patient-centric delivery models.

Assessing how 2025 tariff measures in the United States have amplified supply chain risk, procurement adaptation, and strategic sourcing decisions across dialysis kit ecosystems

The cumulative impact of recent tariff actions in the United States during 2025 has introduced measurable supply chain complexity and cost considerations for dialysis kit stakeholders. Tariff-induced cost pressures have affected upstream raw material flows and component imports, prompting procurement teams to reassess sourcing strategies and inventory policies. As a result, organizations are balancing short-term cost increases against the strategic benefits of diversified sourcing, nearshoring, and strengthened supplier partnerships.

Operational responses have included a re-evaluation of vendor contracts, increased emphasis on supplier visibility, and expedited qualification of alternative manufacturers to mitigate single-source exposures. Clinically, buyers are prioritizing continuity of supply and product equivalence to avoid disruptions to patient care. From a strategic standpoint, tariff uncertainty has acted as a catalyst for investments in supply chain mapping and risk modeling, encouraging stakeholders to quantify vulnerability across supplier tiers and to pursue contractual terms that share risk more equitably. Ultimately, the tariff environment has reinforced the need for supply chain agility, robust contingency planning, and more collaborative commercial relationships between providers and kit manufacturers.

Deep segmentation analysis revealing how modality, end-user setting, materials, distribution channels, and pricing approaches shape procurement and clinical integration

Key segmentation insights reveal how modality, end-user, material composition, sales channel, and pricing model each exert distinct influences on procurement decisions and clinical workflows. Based on modality, distinctions among Hemodialysis Kits, Hemoperfusion Kits, and Peritoneal Dialysis Kits determine not only clinical compatibility with treatment protocols but also the complexity of component assemblies and sterilization needs. Consequently, clinical teams weigh modality-specific performance characteristics alongside logistical requirements to ensure seamless integration within care pathways.

Based on end user, the needs of Ambulatory Surgical Centers diverge from those of Dialysis Centers, Home Healthcare programs, and Hospitals, with each setting prioritizing factors such as kit portability, ease of use, and supply redundancy differently. Based on material, selection between Polyethylene and PVC impacts both biocompatibility considerations and environmental disposal practices, which in turn influence procurement specifications and sustainability commitments. Based on sales channel, the choice between Direct Sales, Distribution Partners, and Online procurement affects lead times, price negotiation leverage, and post-sale service expectations. Finally, based on pricing model, the preference for Disposable Kits versus Reusable Kits shapes inventory policies, sterilization protocols, and long-term cost-of-care calculations. When evaluated together, these segmentation axes guide targeted product development, tailored commercial strategies, and procurement frameworks that align clinical objectives with operational realities.

Comparative regional perspectives highlighting how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence regulation, sourcing, and adoption of dialysis kits

Regional dynamics exert substantial influence on regulatory frameworks, supply chain topology, and clinical adoption patterns in the dialysis kits space. In the Americas, procurement and clinical pathways reflect diverse healthcare payment models and a strong emphasis on outpatient and home-based care expansion, fostering demand for kits optimized for convenience, safety, and remote monitoring compatibility. Stakeholders in this region tend to prioritize supplier reliability and contractual performance commitments that support continuous patient care.

In Europe, Middle East & Africa, regulatory harmonization efforts and heterogeneous healthcare infrastructures create a landscape where compliance, local manufacturing capacity, and distribution networks determine market accessibility. Procurement teams in these territories balance regulatory validation with operational reach to ensure kits meet regional safety standards while remaining logistically feasible. Across Asia-Pacific, rapid adoption of healthcare technologies, investments in local production, and growing emphasis on decentralized care are shaping preferences for cost-effective, scalable kit solutions. Manufacturers and buyers in this region often pursue strategic partnerships to accelerate market entry and to adapt designs to local clinical practices. Collectively, these regional variations inform where manufacturers invest in production, certification, and tailored commercial models to align with local priorities.

Insights into industry competition showing how product differentiation, vertical integration, service ecosystems, and supply chain strategies are reshaping company positioning

Competitive dynamics across manufacturers and suppliers are converging around four strategic pillars: product differentiation through clinical performance, vertical integration of component sourcing, service and support ecosystems, and supply chain resilience. Leading firms are investing in design features that enhance safety, usability, and compatibility with a range of equipment, while simultaneously refining quality systems to expedite regulatory approvals and to maintain product consistency across geographies. This emphasis on differentiation is driving partnerships with clinical institutions to validate real-world performance and to accelerate clinician adoption.

Additionally, several industry players are pursuing vertical integration to secure critical inputs and reduce exposure to tariff-related volatility, enabling more predictable lead times and quality control. Service capabilities-such as training, installation support, and post-sale technical assistance-are increasingly central to commercial value propositions, particularly for ambulatory and home-care segments. At the same time, smaller innovators that focus on niche modalities or materials can exert outsized influence by introducing disruptive assembly methods or sustainable material choices. The result is a marketplace where scale, technical depth, and the ability to provide end-to-end solutions determine competitive advantage and partnership potential.

Actionable recommendations for leaders to strengthen sourcing resilience, clinical alignment, design innovation, and service-led differentiation across dialysis kit programs

Industry leaders should pursue a coordinated set of actions that align clinical value with commercial resilience to capture strategic advantage. First, prioritize supplier diversification and dual-sourcing strategies for critical components to mitigate tariff and geopolitical disruption. Strengthen contractual terms to include clauses for price adjustment, inventory stocking agreements, and accelerated qualification pathways for alternate suppliers. Second, align procurement specifications with clinical teams to ensure product selection reflects both patient safety needs and operational constraints, thereby reducing friction during adoption and limiting waste due to incompatibility.

Third, invest in modular kit design and material innovation to improve usability and to enable rapid adaptation across care settings. Fourth, expand service offerings that accompany product sales-such as training programs, remote monitoring integrations, and localized maintenance-to differentiate on total cost of care rather than unit price alone. Fifth, develop targeted regional strategies that reflect local regulatory landscapes and distribution realities, including consideration for strategic manufacturing footprints and certification roadmaps. By implementing these measures, leaders can enhance resilience, preserve clinical quality, and create defensible commercial positions in an evolving landscape.

Description of the mixed-method research approach combining primary expert interviews, regulatory analysis, and supply chain scenario testing to support actionable industry conclusions

The research underpinning this analysis combines qualitative primary engagement with domain experts and quantitative synthesis of operational and regulatory data to ensure robust, actionable findings. Primary inputs included structured interviews with hospital procurement leaders, clinicians across modalities, supply chain managers, and senior product development executives to capture first-hand perspectives on performance priorities, sourcing constraints, and adoption barriers. These firsthand insights were triangulated with secondary documentation on regulatory guidance, material safety standards, and industry best practices to contextualize operational implications.

Methodological rigor was maintained by cross-validating supplier capability claims against documented certifications and through scenario-based modeling of supply chain disruptions to test resilience measures. Data integrity safeguards included consistency checks, anonymized transcription reviews, and iterative hypothesis testing with subject-matter experts. Limitations of the methodology are acknowledged, including variability in regional procurement practices and the rapid evolution of regulatory interpretations, which necessitate periodic reassessment. Nonetheless, this approach yields a pragmatic synthesis intended to guide actionable decisions and to inform targeted follow-on analyses tailored to specific organizational needs.

Concluding synthesis that distills clinical, procurement, and supply chain priorities into actionable strategic focus areas for improving dialysis kit availability and patient care

In closing, the dialysis kits environment is defined by the interplay between clinical imperatives, procurement strategy, and supply chain realities. Decision-makers must navigate modality-specific requirements, end-user differences, material trade-offs, distribution choices, and pricing models to deliver safe, efficient care. Tariff developments and regional variations further complicate sourcing decisions, but they also create opportunities for strategic differentiation through resilient sourcing, design innovation, and service-based offerings.

Moving from analysis to implementation requires a disciplined approach that aligns clinical teams with procurement, invests in supplier relationships and contingency planning, and prioritizes product features that reduce operational friction. By focusing on these priorities, organizations can protect patient outcomes while achieving more predictable procurement performance. The synthesis provided here is intended to inform executive-level planning and to catalyze targeted initiatives that improve both the quality and continuity of dialysis care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Dialysis Kits Market, by Material

  • 8.1. Polyethylene
  • 8.2. PVC

9. Dialysis Kits Market, by Modality

  • 9.1. Hemodialysis Kits
  • 9.2. Hemoperfusion Kits
  • 9.3. Peritoneal Dialysis Kits

10. Dialysis Kits Market, by Pricing Model

  • 10.1. Disposable Kits
  • 10.2. Reusable Kits

11. Dialysis Kits Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Dialysis Centers
  • 11.3. Home Healthcare
  • 11.4. Hospitals

12. Dialysis Kits Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distribution Partners
  • 12.3. Online

13. Dialysis Kits Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Dialysis Kits Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Dialysis Kits Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Dialysis Kits Market

17. China Dialysis Kits Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Allmed Medical GmbH
  • 18.6. AngioDynamics, Inc.
  • 18.7. Asahi Kasei Medical Co., Ltd.
  • 18.8. Atlantic Biomedical Pvt. Ltd.
  • 18.9. B. Braun Melsungen AG
  • 18.10. Baxter International Inc.
  • 18.11. Bellco S.r.l.
  • 18.12. Dialife SA
  • 18.13. Farmasol
  • 18.14. Fresenius Medical Care AG & Co. KGaA
  • 18.15. Guangdong Kanghua Healthcare Co., Ltd.
  • 18.16. JMS Co., Ltd.
  • 18.17. Kawasumi Laboratories, Inc.
  • 18.18. Mar Cor Purification, Inc.
  • 18.19. Medline Industries, Inc.
  • 18.20. Nikkiso Co., Ltd.
  • 18.21. Nipro Corporation
  • 18.22. NxStage Medical, Inc.
  • 18.23. Outset Medical, Inc.
  • 18.24. Pall Corporation
  • 18.25. Poly Medicure Limited
  • 18.26. Rockwell Medical, Inc.
  • 18.27. Teleflex Incorporated
  • 18.28. Thermo Fisher Scientific Inc.
  • 18.29. Toray Medical Co., Ltd.
  • 18.30. Zhejiang Asia-Pacific Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIALYSIS KITS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIALYSIS KITS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIALYSIS KITS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIALYSIS KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIALYSIS KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIALYSIS KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIALYSIS KITS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIALYSIS KITS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIALYSIS KITS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIALYSIS KITS MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIALYSIS KITS MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIALYSIS KITS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMODIALYSIS KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMODIALYSIS KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMODIALYSIS KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMOPERFUSION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMOPERFUSION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMOPERFUSION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIALYSIS KITS MARKET SIZE, BY PERITONEAL DIALYSIS KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIALYSIS KITS MARKET SIZE, BY PERITONEAL DIALYSIS KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIALYSIS KITS MARKET SIZE, BY PERITONEAL DIALYSIS KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISPOSABLE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISPOSABLE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISPOSABLE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIALYSIS KITS MARKET SIZE, BY REUSABLE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIALYSIS KITS MARKET SIZE, BY REUSABLE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIALYSIS KITS MARKET SIZE, BY REUSABLE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIALYSIS KITS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIALYSIS KITS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIALYSIS KITS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIALYSIS KITS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIALYSIS KITS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIALYSIS KITS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIALYSIS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS DIALYSIS KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIALYSIS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. GCC DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 107. GCC DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 108. GCC DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 109. GCC DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GCC DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. G7 DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. G7 DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 126. G7 DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 127. G7 DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. G7 DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. NATO DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. NATO DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 132. NATO DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 133. NATO DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. NATO DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)